公司資料
Foghorn Therapeutics 股價、新聞與催化劑
- 股票代碼:
- FHTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.02 USD (-30.82%)
收盤價
最後更新: 2026年10月2日
213M USD
市值
股價為何變動
最新公司動態「Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities」發布後，FHTX 於 2026年10月1日 收於 $2.92，較前一交易日下跌 18.2%。該變動發生在與這則合作動態對應的交易時段。
公司概覽
業務概覽
Foghorn Therapeutics is an oncology company focused on chromatin biology and gene-regulation targets. Its platform seeks to create differentiated cancer therapies through epigenetic control.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Foghorn sits in specialty oncology biotechnology.
商業模式特徵
The company depends on translational data, target validation, and the possibility of building a new oncology platform.
生技產業定位
Foghorn is a high-catalyst oncology name with strong dependence on early data quality.
未來催化劑
- Foghorn’s next three months are about its chromatin-regulation oncology programs and any data that show the platform can still produce differentiated human results. The market will care most about whether the synthetic-lethality thesis can keep moving forward.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。